Cleveland Clinic and IBM Use AI to Accelerate Immunotherapy Target Discovery
• Scientists at Cleveland Clinic and IBM using AI to identify drug targets in immune system
• AI models account for molecular shape changes over time to understand immune cell & antigen interactions
• AI approach faster, more accurate than previous models; can focus search for immunotherapy treatments
• Partnership allows pushing boundaries of AI & health sciences to advance cancer therapy target development
• Part of larger Discovery Accelerator partnership applying computing tech like AI to accelerate biomedical research